World's Best Scientists 2026 revealed!
Raf Sciot

Raf Sciot

D-Index & Metrics

Medicine

D-Index
107
Citations
42325
World Ranking
6254
National Ranking
71

Overview

Raf Sciot is affiliated with KU Leuven in Belgium and has contributed extensively to the field of medicine, with a particular focus on pulmonary and respiratory medicine, rheumatology, oncology, neurology, and genetics. Their research spans a range of topics connected to tumor diagnosis and treatments, encompassing sarcoma, glioma, vascular tumors, soft tissue tumors, bone tumors, neurofibromatosis, schwannoma cases, and gastrointestinal tumor research.

The scientist's work has been published in various respected venues, including Neuro-Oncology, Cancer Research, Genes Chromosomes and Cancer, Sarcoma, and the International Journal of Molecular Sciences. These frequent publication venues underscore the breadth of their research engagement across oncology and related medical disciplines.

Raf Sciot's notable recent papers include:

  • "Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization," 2021, Nature Neuroscience
  • "Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study," 2020, The Lancet Neurology
  • "ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition," 2021, Blood
  • "MDM2 Amplified Sarcomas: A Literature Review," 2021, Diagnostics
  • "YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases," 2021, Modern Pathology

The scientist has collaborated frequently with a number of coauthors, including Patrick Schöffski, Isabelle Vanden Bempt, Frederik De Smet, Steven De Vleeschouwer, and Agnieszka Woźniak. These collaborations highlight ongoing teamwork within their specialized fields.

In addition to articles, Raf Sciot has contributed to book publications, notably with Springer Nature. One such publication is titled Adipocytic, Vascular and Skeletal Muscle Tumors, released in 2020.

Best Publications

  • Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

    Marc Cruts;Ilse Gijselinck;Julie van der Zee;Sebastiaan Engelborghs

  • Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.

    Allan T van Oosterom;Ian Judson;Jaap Verweij;Sigrid Stroobants

  • Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

    B. Oosthuyse;L. Moons;E. Storkebaum;H. Beck

  • Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

    Gert Van Assche;Marc Van Ranst;Raphael Sciot;Bénédicte Dubois

  • KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

    Maria Debiec-Rychter;Raf Sciot;Axel Le Cesne;Marcus Schlemmer

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

    S. Stroobants;J. Goeminne;M. Seegers;S. Dimitrijevic

  • The der(17)t(x;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Marc Ladanyi;Man Yee Lui;Cristina R Antonescu;Amber Krause-Boehm

  • Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization.

    Ana Rita Pombo Antunes;Isabelle Scheyltjens;Francesca Lodi;Julie Messiaen

  • Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

    Maria Debiec-Rychter;Jan Cools;Herlinde Dumez;Raf Sciot

  • Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

    Twinkal C. Pansuriya;Ronald van Eijk;Pio d'Adamo;Maayke A. J. H. van Ruler

  • Prominent Axonopathy in the Brain and Spinal Cord of Transgenic Mice Overexpressing Four-Repeat Human tau Protein

    Kurt Spittaels;Chris Van den Haute;Jo Van Dorpe;Koen Bruynseels

  • Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

    M. Debiec-Rychter;H. Dumez;I. Judson;B. Wasag

  • Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

    Piotr Rutkowski;Martine Van Glabbeke;Cathryn J Rankin;Wlodzimierz Ruka

  • The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study.

    Peter Van Eyken;Raf Sciot;Francesco Callea;Kris Van Der Steen

  • Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.

    C. D. M. Fletcher;M. Akerman;P. Dal Cin;I. De Wever

  • Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study.

    Martine Van Glabbeke;Jaap Verweij;Paolo G Casali;Axel Le Cesne

  • Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions

    Bénédicte Dubois;Stefan Masure;Ursula Hurtenbach;Liesbet Paemen

  • PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).

    Pedram Argani;Cristina R Antonescu;Jérôme Couturier;Jean-Christophe Fournet

  • Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

    Munir R. Tanas;Andrea Sboner;Andre M. Oliveira;Michele R. Erickson-Johnson

Frequent Co-Authors

Paola Dal Cin
Paola Dal Cin Harvard Medical School
Christopher D.M. Fletcher
Christopher D.M. Fletcher Brigham and Women's Hospital
Piotr Rutkowski
Piotr Rutkowski Maria Sklodowska-Curie National Research Institute of Oncology
Fredrik Mertens
Fredrik Mertens Lund University
Judith V.M.G. Bovée
Judith V.M.G. Bovée Leiden University Medical Center
Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Nils Mandahl
Nils Mandahl Lund University
Eric Legius
Eric Legius KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many aspiring healthcare professionals in the USA are exploring flexible study options beyond traditional medical schools. For those interested in nursing, a range of online degrees and certifications can open rewarding clinical and leadership roles.

Choosing the most affordable online nurse practitioner programs is a practical way to advance your career without significant financial burden. More students are also considering nursing school online for its accessibility and the ability to balance studies with current work or family commitments.

For nurses seeking a terminal degree, pursuing an online phd in nursing offers an opportunity to tap into research, education, or advanced clinical practice from anywhere in the country. Those with an RN license can build on their credentials through accessible rn to bsn online cost programs, often at a fraction of the price and time of traditional pathways.

Online healthcare degrees can provide robust options and adaptable career pathways, helping students meet the demands of the healthcare landscape in the USA.

Best Scientists Citing Raf Sciot

Trending Scientists

Recently Published Articles